K. Rajender (Raj) Reddy, M.D.
Professor of Medicine at the Hospital of the University of Pennsylvania
Director of Hepatology, HUP, Hospital of the University of Pennsylvania
Medical Director of Liver Transplantation, HUP, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Division of Gastroenterology
HUP
2 Dulles
Philadelphia, PA 19104
HUP
2 Dulles
Philadelphia, PA 19104
Office: 215-662-4276
Fax: 215-349-5915
Fax: 215-349-5915
Publications
Education:
M.B.B.S.
Osmania Medical College, Hyderabad, India, 1972.
M.B.B.S.
Osmania Medical College, Hyderabad, India, 1972.
Post-Graduate Training
Rotation House Surgeon, Osmania General Hospital, Hyderabad, India , 1972-1973.
Pre-Registration House Office, Aberdeen Teaching Hospitals, Aberdeen, UK , 1974-1975.
Senior House Officer, St. Edmund’s Hospital, Northampton, UK , 1975-1976.
Resident in Internal Medicine, Misericordia Hospital, Lincoln Hospital Affiliation, New York Medical College, New York, now known as Our Lady of Mercy Medical Center , 1977-1980.
Fellowship, Gastroenterology, East Tennessee State University College of Medicine, Tennessee , 1980-1982.
Fellowship, Hepatology, University of Miami School of Medicine, Miami, Florida , 1982-1983.
Permanent linkRotation House Surgeon, Osmania General Hospital, Hyderabad, India , 1972-1973.
Pre-Registration House Office, Aberdeen Teaching Hospitals, Aberdeen, UK , 1974-1975.
Senior House Officer, St. Edmund’s Hospital, Northampton, UK , 1975-1976.
Resident in Internal Medicine, Misericordia Hospital, Lincoln Hospital Affiliation, New York Medical College, New York, now known as Our Lady of Mercy Medical Center , 1977-1980.
Fellowship, Gastroenterology, East Tennessee State University College of Medicine, Tennessee , 1980-1982.
Fellowship, Hepatology, University of Miami School of Medicine, Miami, Florida , 1982-1983.
Selected Publications
Blonski W,Reddy KR: Evaluation of nonmalignant liver masses.Curr Gastroenterol Rep 8: 38-45, 2006.Merriman NA,Porter SB,Brensinger CM,Reddy KR,Chang KM: Racial difference in mortality among US veterans with HIV/HCV coinfection. Am J Gastroenterol 101: 760-767, 2006.
Porrett PM,Peterman H, Rosen M,Sonnad S, Soulen M,Markmann JF,Shaked A,Furth E,Reddy KR,Olthoff K: Lack of benefit of pre-transplant locoregional hepatic artery therapy for hepatocellular carcinoma in the current MELD era. Liver Transpl 12(4): 665-673, 2006.
Itkin M,Trerotola SO, Stavropoulos SW,Patel A,Mondschein JI,Soulen MC,Tuite CM,Shlansky-Goldberg RD,Faust TW,Reddy KR,Solomon JA,Clark TW: Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation J Vasc Interv Radiol 17: 55-62, 2006.
Howell CD,Jeffers LS,Cassidy W, Reddy KR,Hu S,Lee JS: Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients:Safety,tolerability and impact on sustained virologic response. Journal of Viral Hepatitis 13: 371-376, 2006.
Dickson RC,Terrault NA,Ishitani M,Reddy KR,Sheiner P,Luketic V,Soldevila-Pico C, Fried M, Jensen D,Brown RS Jr,Horwith G,Brundage R,Lok A: Protective antibody levels and dose requirements for IV 5 % Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl 12: 124-133, 2006.
Kotlyar DS,Campbell MS,Reddy KR: Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol 101: 1370-1378, 2006.
Kozin ED,Reddy KR: Is long-term survivial of liver transplant recipients improved by mycophenalate mofetil combination therapy ? Nat Clin Pract Gastroenterol Hepatol 3: 132-133, 2006.
Jensen DM,Morgan TR,Marcellin P,Pockros PJ,Reddy KR,Hadziyannis SJ,Ferenci P,Ackrill AM, Willems B: Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a(40 kd)/ribavirin therapy. Hepatology 43: 954-960, 2006.
Ferenci P,Fried MW,Shiffman ML,Smith CI,Marinos G,Goncales FL,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Chaneac M,Reddy KR: Predicting sustained virologic responses in chronic hepatitis C patients treated with peginterferon alfa-2a(40 KD)/ribavirin. J Hepatol 43: 425-433, 2005.
